Nine-Year Median Follow-up of Cardiotoxicity and Efficacy of Trastuzumab Concurrently With Anthracycline-Based and Anthracycline-Free Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer Patients
Xuexin He, Xiaolan Dai, Jiali Ji, Hong Liu, Ganggang Shi, Sai‐Ching J. Yeung
Topics & Concepts
MedicineTrastuzumabCardiotoxicityInternal medicineAnthracyclineEpirubicinDocetaxelBreast cancerChemotherapyOncologyRegimenCancerGastroenterologyBreast Cancer Treatment StudiesChemotherapy-induced cardiotoxicity and mitigationHER2/EGFR in Cancer Research